Open AccessModern views on development mechanisms and tactics for treatment of patients with gallbladder disease associated with metabolic syndrome
Author(s) -
В. А. Ахмедов,
О. В. Гаус
Publication year - 2019
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2019-2-13(388)-52-56
Subject(s) - metabolic syndrome , dyslipidemia , medicine , ursodeoxycholic acid , disease , insulin resistance , fatty liver , diabetes mellitus , medical prescription , intensive care medicine , gallbladder , gallbladder disease , population , gastroenterology , endocrinology , pharmacology , environmental health
The high prevalence of metabolic syndrome in population has led to the cholelithiasis is important problem of modern health care along with coronary heart disease, arterial hypertension and diabetes. The main role in the formation of gallbladder pathology in patients with metabolic syndrome belongs to insulin resistance, atherogenic dyslipidemia, and non‑alcoholic fatty liver disease. Тhe prescription of ursodeoxycholic acid is pathogenetically justified. This article presents modern views on the mechanisms formation of gallstone disease in the conditions of metabolic disorders and management of this patients based on the results own research.